Expert Interview
Discussing the recent phase 2 data of barzolvolimab in two of the most common forms of CIndU - Cold Urticaria and symptomatic dermographism
Ticker(s): CLDXInstitution: The Corvallis Clinic
- Allergist who sees 100 patients with chronic urticaria
- Works in a multispeciality clinic seeing adult and pediatric patients
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
